Evaluation of the therapeutic activity of tulathromycin against swine respiratory disease on farms in Europe

Veterinary Therapeutics

Volumn 6, Issue 2, 2005, Pages 203-213

  Nanjiani, Ian A ^a   McKelvie, Jo ^a   Benchaoui, Hafid A ^a   Godinho, Kevin S ^a   Sherington, John ^a   Sunderland, Simon J ^a   Weatherley, Andrew J ^a   Rowan, Tim G ^a  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; DISACCHARIDE; DITERPENE; DRUG DERIVATIVE; FLORFENICOL; HETEROCYCLIC COMPOUND; THIAMPHENICOL; TIAMULIN; TULATHROMYCIN;

ANIMAL; ANIMAL DISEASE; ARTICLE; CATTLE DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EPIDEMIC; EUROPE; HOSPITALIZATION; INTRAMUSCULAR DRUG ADMINISTRATION; MULTICENTER STUDY; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL; SWINE; SWINE DISEASE; TREATMENT OUTCOME;

ANIMALS; ANTI-BACTERIAL AGENTS; DISACCHARIDES; DISEASE OUTBREAKS; DITERPENES; EUROPE; HETEROCYCLIC COMPOUNDS; INJECTIONS, INTRAMUSCULAR; PASTEURELLOSIS, PNEUMONIC; SEVERITY OF ILLNESS INDEX; SWINE; SWINE DISEASES; THIAMPHENICOL; TREATMENT OUTCOME;

ACTINOBACILLUS PLEUROPNEUMONIAE; ANIMALIA; MYCOPLASMA HYOPNEUMONIAE; PASTEURELLA MULTOCIDA; SUS SCROFA;

EID: 24044513016     PISSN: 15283593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Taylor DJ: Pig Diseases, ed 5. Foxton, Cambridge, UK, Burlington Press, 1989, pp 118-162.
2. Straw B, Duran O: Causal factors in swine pneumonia, in Howard JL, Smith RA (eds): Current Veterinary Therapy 4: Food Animal Practice, ed 4. Philadelphia, WB, Saunders, 1999, pp 437-443.
3. Maes DG, Deluyker H, Verdonck M, et al: Non-infectious factors associated with macroscopic and microscopic lung lesions in slaughter pigs from farrow-to-finish herds. Vet Rec 148:41-46, 2001.
4. Done S, White M: Porcine respiratory disease and complexes: The story to date. In Pract 25:410-417, 2003.
5. Done SH: Environmental factors affecting the severity of pneumonia in pigs. Vet Rec 128:582-586, 1991.
6. Ross RF: Mycoplasmal diseases, in Leman AD, Straw B, Glock R, et al (eds): Diseases of Swine, ed 7. Ames, Iowa State University Press, 1992, pp 537-551.
7. Letavic MA, Bronk BS, Bertsche CD, et al: Synthesis and activity of a novel class of tribasic macrocyclic antibiotics: The triamilides. Bioorg Med Chem Lett 12:2771-2774, 2002.
8. Nowakowski M, Linhares M, Bunger A, et al: Pharmacokinetic profiles of some triamilides, a new class of macrolide, in mice and cattle. J Vet Pharmacol Ther 26:100, 2003.
9. Norcia LJ, Silvia AM, Santoro SL, et al: In vitro microbiological characterization of a novel azalide, two triamilides and an azalide ketal against bovine and porcine respiratory pathogens. J Antibiot (Tokyo) 57:280-288, 2004.
10. Kamicker BJ, Mann DD, Hassfurther RL, et al: Therapeutic and metaphylactic activity of azalides and triamilides in the treatment of naturally occurring bovine respiratory disease. J Vet Pharmacol Ther 26:233-234, 2003.
11. Kamicker BJ, Mann DD, Hassfurther RL, et al: Therapeutic and prophylactic activity of azalides and triamilides in the treatment of bovine respiratory disease. J Vet Pharmacol Ther 26:234, 2003.
12. Benchaoui HA, Nowakowski MA, Sherington J, et al: Pharmacokinetics and lung tissue concentrations of tulathromycin in swine. J Vet Pharmacol Ther 27:203-210, 2004.
13. The European Union Committee for Veterinary Medicinal Products: EU Note for Guidance: Good Clinical Practice for the Conduct of Clinical Trials for Veterinary Medicinal Products. Brussels, Belgium, FEDESA, July 1994.
14. National Committee for Clinical Laboratory Standards (NCCLS; now Clinical and Laboratory Standards Institute [CLSI]): Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals [approved standard]. Doc. M31-A, Vol. 19, No. 11, June 1999.
15. Tanner AC, Wu CC: Adaptation of the Sensititre broth microdilution technique to antimicrobial susceptibility testing of Mycoplasma gallisepticum. Avian Dis 36:714-717, 1992.
16. Voorspoels J, D'Haese E, De Craene BA, et al: Pharmacokinetics of florfenicol after treatment of pigs with single oral or intramuscular doses or with medicated feed for three days. Vet Rec 145:397-399, 1999.
17. Landén A, Horn AF, Rantzien M, Franklin A: MIC values for porcine Actinobacillus pleuropneumoniae isolated in Sweden. Proc 16th Int Pig Vet Soc Congr: 142, 2000.
18. Aarestrup FM, Jensen NE: Susceptibility testing of Actinobacillus pleuropneumoniae in Denmark. Evaluation of three different media of MIC-determinations and tablet diffusion tests. Vet Microbiol 64:299-305, 1999.
19. 2 and serum) on MIC values of tulathromycin against Haemophilus somnus [abstract 532]. Proc 23rd World Buiatrics Congr:70-71, 2004.
20. Barry AL, Fuchs PC: Influence of the test medium on azithromycin and erythromycin regression statistics. Eur J Clin Microbiol Infect Dis 10:846-849, 1991.
21. Carbon C: Pharmacodynamics of macrolides, azalides and streptogramins: Effect on extracellular pathogens. Clin Infect Dis 27:28-32, 1998.
22. 2. J Antimicrob Chemother 41:387-389, 1998.
23. Barigazzi G, Raffo A, Guarini CPB: Sensitivity to tilmicosin (Elanco AH) of recent porcine lung isolates and correlation between minimal inhibitory concentration (MIC) and Kirby-Bauer test. Proc 16th Int Pig Vet Soc Congr: 138, 2000.
24. Pfaller MA, Jones RN, Walter DH, The Quality Control Study Group: Proposed quality control guidelines for National Committee for Clinical Laboratory Standards susceptibility tests using the veterinary antimicrobial agent tiamulin. Diagn Microbial Infect Dis 40:67-70, 2001.